Idarucizumab Reverses Dabigatran Anticoagulant Activity in Healthy Chinese Volunteers: A Pharmacokinetics, Pharmacodynamics and Safety Study
media
posted on 2020-07-16, 15:41 authored by Zining Wang, Xia Zhao, Pengkang He, Shuqing Chen, Jie Jiang, Akiko Harada, Steven Brooks, Yimin Cui<p><strong>Article full
text</strong></p>
<p> </p>
<p><br></p><p><br></p>
<p> </p>
<p>The above summary slide represents
the opinions of the authors. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2020.</p>
